Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/207542
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAiassa, Lara-
dc.contributor.authorBattaglia, Giuseppe-
dc.contributor.authorRizzello, Loris-
dc.date.accessioned2024-02-13T11:21:34Z-
dc.date.available2024-02-13T11:21:34Z-
dc.date.issued2023-12-29-
dc.identifier.issn2688-4089-
dc.identifier.urihttp://hdl.handle.net/2445/207542-
dc.description.abstractMacrophages play a crucial role in our immune system, preserving tissue health and defending against harmful pathogens. This article examines the diversity of macrophages influenced by tissue-specific functions and developmental origins, both in normal and disease conditions. Understanding the spectrum of macrophage activation states, especially in pathological situations where they contribute significantly to disease progression, is essential to develop targeted therapies effectively. These states are characterized by unique receptor compositions and phenotypes, but they share commonalities. Traditional drugs that target individual entities are often insufficient. A promising approach involves using multivalent systems adorned with multiple ligands to selectively target specific macrophage populations based on their phenotype. Achieving this requires constructing supramolecular structures, typically at the nanoscale. This review explores the theoretical foundation of engineered multivalent nanosystems, dissecting the key parameters governing specific interactions. The goal is to design targeting systems based on distinct cell phenotypes, providing a pragmatic approach to navigating macrophage heterogeneity's complexities for more effective therapeutic interventions.-
dc.format.extent25 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAIP Publishing LLC-
dc.relation.ispartofBiophysics Reviews, 2023, vol. 4, num. 4-
dc.rightscc by (c) Aiassa, Lara et al., 2023-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))-
dc.subject.classificationNanopartícules-
dc.subject.classificationSistema immunitari-
dc.subject.otherNanoparticles-
dc.subject.otherImmune system-
dc.titleThe multivalency game ruling the biology of immunity-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.doihttps://doi.org/10.1063/5.0166165-
dc.date.updated2024-02-12T10:27:32Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6607023-
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
2023_BioRev_Multivalency_AiassaL.pdf2.46 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons